The Artificial Intelligence Act (EU 2024/1689) Whitepaper: Key Obligations, Risks, and Compliance

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

The AI Act sets a global precedent for responsible AI development—balancing innovation with accountability and ensuring AI technologies uphold safety, transparency, and fundamental rights

REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Whitepaper

The Artificial Intelligence Act (Regulation (EU) 2024/1689) is the European Union’s first-ever legislation to comprehensively regulate AI systems. It establishes a risk-based framework to ensure AI technologies are developed and deployed responsibly, balancing innovation with accountability.

This whitepaper provides an essential overview of the AI Act, helping businesses, developers, and public authorities understand the law’s key requirements, who it applies to, and how to prepare for compliance.

Discover the classification of AI systems, specific obligations for high-risk and general-purpose AI models, enforcement mechanisms, penalties, and the upcoming implementation timelines.

Stay ahead of the curve and equip yourself with the knowledge needed to navigate AI regulation confidently.

 

Key Topics Covered

  • What the Artificial Intelligence Act is and why it is needed
  • Who must comply: providers, deployers, importers, distributors, authorised representatives
  • Key definitions: AI systems, systemic risk, general-purpose AI models
  • Risk-based classification of AI systems: Unacceptable, High, Limited, and Minimal risk
  • Detailed obligations for high-risk AI systems, including quality management, transparency, human oversight, and cybersecurity
  • Additional requirements for General-Purpose AI Models with systemic risk
  • Penalties for non-compliance, including fines up to €35 million
  • Practical steps businesses and developers should take now to prepare
  • Important deadlines and the AI Act’s implementation timeline

Learn about AI system risk classifications, compliance obligations, penalties, and timelines and stay ahead of EU AI regulations.

Download your AI Act Compliance Whitepaper

 

Hero Image AI Act WP MedTech

Who this is for

This whitepaper is designed for:

    • AI system developers and providers launching solutions within the EU

    • Organisations deploying AI technologies in operations or services

    • Medical device manufacturers integrating AI into their products

    • Compliance, legal, and regulatory professionals overseeing AI governance

    • Public sector bodies and private organisations using AI in decision-making

    • Anyone seeking to understand and implement the AI Act’s requirements

View our other resources and company news

GMP Raising the bar Blog series Header image May 25 Blog

Continuous Inspection Readiness Beyond Mock Audits

Traditional mock audits aren’t enough. With rising unannounced inspections, pharmaceutical and biotech firms must embrace continuous inspection readiness. This article explores how to embed compliance ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

How Rephine Accelerates Digital QMS Transformation in Pharma

Rephine helps pharmaceutical and biotech companies transition to digital QMS platforms like Veeva Vault, MasterControl, or TrackWise. From vendor-neutral selection to full GxP-compliant validation and ...
Read More
CPV Header image blog apr 25 Blog

Threat Modelling in Medical Devices: STRIDE for MDR/IVDR Cybersecurity Compliance

Understand how STRIDE and other threat modelling techniques help medical device manufacturers meet MDR/IVDR cybersecurity requirements—plus real-world examples and expert insights.
Read More
Medical Device Guide

Security Risk Management for Medical Devices: MDR & IVDR Compliance Whitepaper

Understand how to embed cybersecurity into the medical device lifecycle with this expert guide from Rephine. Includes MDR/IVDR, FDA, and IMDRF guidance on SRM, threat ...
Read More
Pharma equipment qualification hero image Case Study

Pharmaceutical Equipment Qualification Case Study

See how Rephine helped a global pharmaceutical manufacturer accelerate equipment qualification using a GMP-aligned, risk-based strategy—saving time and improving compliance.
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Digitalization in Pharma: GxP Compliance with Rephine

Rephine enables pharma companies to transform digitally—ensuring GxP compliance, system validation (CSV), and data integrity across platforms like LIMS, MES, and QMS.
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Building a Strong Quality Culture in Pharma

A mature quality culture is more than compliance—it’s a business advantage. Explore how pharma companies can foster accountability, reduce risk, and embed quality into everyday ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Annex 1 Compliance: Sterile Manufacturing Updates Explained

The revised EU Annex 1 brings sweeping changes for sterile manufacturers. Learn what’s new, from contamination control to supplier audits, and how to prepare.
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Supplier Qualification in GxP Compliance: Strengthening Pharmaceutical Supply Chains

Supplier qualification is critical to GxP compliance and regulatory readiness. Discover how Rephine helps pharma companies manage supplier risks, ensure data integrity, and maintain supply ...
Read More
Contact Us